Maternal autoantibodies can cross the placenta and cause fetal damage. This article summarizes the development and management of fetal thyroid goiter in response to maternal Graves' disease and/or its treatment with antithyroid medication, fetal heart block due to maternal anti-Ro and anti-La antibodies, fetal athrogryposis multiplex congenita in association with maternal myasthenia gravis and fetal brain hemorrhage due to maternal autoimmune thrombocytopenia.
Keywords: Graves’ disease; Maternal autoantibodies; anti-Ro and anti-La antibodies; athrogryposis multiplex congenital; autoimmune thrombocytopenia; fetal brain hemorrhage; fetal heart block; fetal thyroid goiter; myasthenia gravis.